Nonzero Risk of Hepatocellular Carcinoma Even after Sustained Virological Response

참고문헌 (10)

1. Pawlotsky JM, "New hepatitis C therapies: the toolbox, strategies, and challenges", Gastroenterology, 146, pp.1176~1192 (2014)
2. Yamashita N, "Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes", J Gastroenterol, 49, pp.1504~1513 (2014)
3. AASLD, "IDSA HCV Guidance Panel", Hepatitis C guidance: AASLDIDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus, 2015, pp.62, 932~954
4. Morgan RL, "Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies", Ann Intern Med, 158(5 Pt 1), pp.329~337 (2013)
5. Li DK, "Impact of hepatitis C virus eradication on hepatocellular carcinogenesis", Cancer, 121, pp.2874~2882 (2015)
6. Morgan TR, "Outcome of sustained virological responders with histologically advanced chronic hepatitis C", Hepatology, 52, pp.833~844 (2010)
7. Asahina Y, "Alpha-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C", Hepatology, 58, pp.1253~1262 (2013)
8. Toyoda H, "Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection", J Gastroenterol Hepatol, 30, pp.1183~1189 (2015)
9. Keol Lee, "Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index", Gut and Liver, 10(5), pp.796~802 (2016), 거트앤리버 발행위원회
10. George PM, "Pharmacology and therapeutic potential of interferons", Pharmacol Ther, 135, pp.44~53 (2012)

관련 논문AI추천